Sunshine Biopharma Inc (SBFM)

[Glopez]

Repeated reverse splits, failure to engage investor base with meaningful communication, stepping on shareholders; overdue transgenic mouse study results, building the company up & enriching board members at the expense of shareholders.

Alleging that long time affiliates of the company are “independent.”

SMH… the list of failures is long for this company. I doubt they’ll get into the NASDAQ, if they do, the price will just drop and the company will get delisted, but it’ll probably try to save itself prior to delisting (if the company even gets to the NASDAQ) by stepping on shareholders again via reverse splits.

This company stock is doing terribly because the management is terrible, not because it’s on the OTC. The management has shown an IDGAF attitude towards investors & failed to grow shareholder value in a meaningful way.

Everything this company has been doing to its investors will be a stain on the company in the future, causing selling pressure to increase & remain, even after a period of strong buying pressure.

Selling pressure isn’t going to diminish & you can count on this reaching sub-penny land soon, and even after news and a brief period of high buying pressure, this will plummet, because no intelligent person wants to be stuck holding shares in a company whose management has an IDGAF attitude towards investors.

Bad decisions, bad deals, poor management, and a lack of concern for investor relations is why this company will fail.

Selling pressure is here to stay.